Dahmen, N <br/><br/>
Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients.  [electronic resource] 

 -  Schizophrenia research  Apr 2001 
 - 223-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Letter 
<br/><br/><label>ISSN: </label>0920-9964 
<br/><br/><label>Standard No.: </label>10.1016/s0920-9964(99)00147-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--adverse effects<br/>Female<br/>Gene Frequency--genetics<br/>Humans<br/>Male<br/>Polymorphism, Genetic--genetics<br/>Receptors, Dopamine D2--genetics<br/>Receptors, Dopamine D3<br/>Schizophrenia--drug therapy